CH488681A - Verfahren zur Herstellung von 3-Keto-19-nor- 4-10-isosteroiden - Google Patents

Verfahren zur Herstellung von 3-Keto-19-nor- 4-10-isosteroiden

Info

Publication number
CH488681A
CH488681A CH1096565A CH1096565A CH488681A CH 488681 A CH488681 A CH 488681A CH 1096565 A CH1096565 A CH 1096565A CH 1096565 A CH1096565 A CH 1096565A CH 488681 A CH488681 A CH 488681A
Authority
CH
Switzerland
Prior art keywords
isosteroids
keto
preparation
Prior art date
Application number
CH1096565A
Other languages
English (en)
Inventor
Farkas Eugene
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH488681A publication Critical patent/CH488681A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J15/00Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1096565A 1964-08-13 1965-08-04 Verfahren zur Herstellung von 3-Keto-19-nor- 4-10-isosteroiden CH488681A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US389484A US3341558A (en) 1964-08-13 1964-08-13 19-nor-10alpha-delta4-androstene-3, 17-dione and process for the production thereof

Publications (1)

Publication Number Publication Date
CH488681A true CH488681A (de) 1970-04-15

Family

ID=23538454

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1096565A CH488681A (de) 1964-08-13 1965-08-04 Verfahren zur Herstellung von 3-Keto-19-nor- 4-10-isosteroiden

Country Status (8)

Country Link
US (1) US3341558A (de)
BE (1) BE668308A (de)
BR (1) BR6572080D0 (de)
CH (1) CH488681A (de)
DE (1) DE1518775A1 (de)
ES (1) ES316281A1 (de)
GB (1) GB1120814A (de)
NL (1) NL6510599A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470215A (en) * 1967-04-04 1969-09-30 American Home Prod Synthesis of 10-isogonenes and derivatives thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3207753A (en) * 1961-12-04 1965-09-21 Syntex Corp Ring a aromatic 9beta-estratrienes and -19-norpregnatrienes
US3198792A (en) * 1962-06-12 1965-08-03 Philips Corp 10alpha methyl, 9beta hormonal steroids
US3167547A (en) * 1963-11-18 1965-01-26 Syntex Corp 17-tetrahydropyranyl ethers of 19-nor, 3-keto androstanes

Also Published As

Publication number Publication date
BR6572080D0 (pt) 1973-08-14
US3341558A (en) 1967-09-12
BE668308A (de)
DE1518775A1 (de) 1970-01-08
GB1120814A (en) 1968-07-24
NL6510599A (de) 1966-02-14
ES316281A1 (es) 1966-04-01

Similar Documents

Publication Publication Date Title
CH459982A (de) Verfahren zur Herstellung von Polyenketonen
CH448057A (de) Verfahren zur Herstellung von Phenylalkylaminoguanidinen
CH478779A (de) Verfahren zur Herstellung von a-Dithiosemicarbazonen
CH472353A (de) Verfahren zur Herstellung von Pyridin-4-thiolen
CH476717A (de) Verfahren zur Herstellung von Halogenribofuranosiden
CH467268A (de) Verfahren zur Herstellung von 5-Nitroimidazolen
CH440294A (de) Verfahren zur Herstellung von 4-Nitropyrazolen
CH443528A (de) Verfahren zur Herstellung von 4-Brom-3-hydroxychinophthalon
CH478790A (de) Verfahren zur Herstellung von 7-Aminocumarinen
CH473761A (de) Verfahren zur Herstellung von Dibenzocycloheptenylaminen
CH461473A (de) Verfahren zur Herstellung von Dibenzocycloheptenylaminen
CH447170A (de) Verfahren zur Herstellung von N-Alkyl-a-pyrrolidonen
CH473086A (de) Verfahren zur Herstellung von Acetylenaminen
CH478830A (de) Verfahren zur Herstellung von 3-Halogen-Thiadiazolen
CH478833A (de) Verfahren zur Herstellung von Pyrimidopyrimidothiazinen
CH475262A (de) Verfahren zur Herstellung von Pyrazin-4-oxyden
CH442336A (de) Verfahren zur Herstellung von o-Amino-benzonitrilen
CH465639A (de) Verfahren zur Herstellung von L-a-Niederalkyl-hydroxyphenylalaninen
CH458378A (de) Verfahren zur Herstellung von N6-Methyltubercidin
CH471112A (de) Verfahren zur Herstellung von 4- Vinylchroman-4-olen
AT258268B (de) Verfahren zur Herstellung von Tetrahydrotricyclopentadienylendiaminen
AT256812B (de) Verfahren zur Herstellung von Cyclopentano-ω-önanthlactam
CH443290A (de) Verfahren zur Herstellung von 17a-Äthoxy-6-chlor-6-dehydro-progesteron
CH458340A (de) Verfahren zur Herstellung von Phosphonohalogenthionaten
CH460754A (de) Verfahren zur Herstellung von a-Acetyldigitoxin

Legal Events

Date Code Title Description
PL Patent ceased